These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 6434583)

  • 1. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
    Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
    Vance ML; Borges JL; Kaiser DL; Evans WS; Furlanetto R; Thominet JL; Frohman LA; Rogol AD; MacLeod RM; Bloom S
    J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
    Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
    J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.
    Borges JL; Blizzard RM; Gelato MC; Furlanetto R; Rogol AD; Evans WS; Vance ML; Kaiser DL; MacLeod RM; Merriam GR; Loriaux DL; Spiess J; Rivier J; Vale W; Thorner MO
    Lancet; 1983 Jul; 2(8342):119-24. PubMed ID: 6134978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
    Shimizu T; Inoue K
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pancreatic tumor GH-releasing factor.
    Thorner MO; Evans WS; Vance M; Borges JL; Blizzard RM; Rogol AD; MacLeod RM; Cronin MJ; Frohman LA; Thominet JL
    Acta Neurochir (Wien); 1985; 75(1-4):72-80. PubMed ID: 2986423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
    Mendelson JH; Mello NK; Teoh SK; Ellingboe J
    J Pharmacol Exp Ther; 1989 Sep; 250(3):902-9. PubMed ID: 2506337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF.
    von Werder K; Losa M; Stalla GK; Bock L; Müller OA
    Acta Neurochir (Wien); 1985; 75(1-4):81-7. PubMed ID: 2986424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits.
    Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T
    Endocrinology; 1983 Dec; 113(6):2081-5. PubMed ID: 6139274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal administration of human pancreatic tumor GH-releasing factor-40 stimulates GH release in normal men.
    Evans WS; Borges JL; Kaiser DL; Vance ML; Sellers RP; MacLeod RM; Vale W; Rivier J; Thorner MO
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1081-3. PubMed ID: 6413525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone response of steers injected with synthetic human pancreatic growth hormone-releasing factors.
    Moseley WM; Krabill LF; Friedman AR; Olsen RF
    J Anim Sci; 1984 Feb; 58(2):430-5. PubMed ID: 6423603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea.
    Berga SL; Mortola JF; Girton L; Suh B; Laughlin G; Pham P; Yen SS
    J Clin Endocrinol Metab; 1989 Feb; 68(2):301-8. PubMed ID: 2493024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily determine the GH elimination rate in healthy young women and men.
    Shah N; Aloi J; Evans WS; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2862-9. PubMed ID: 10443692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationships for the effects of growth hormone-releasing factor-(1-44)-NH2 in young adult men and women.
    Gelato MC; Pescovitz OH; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1984 Aug; 59(2):197-201. PubMed ID: 6330151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pancreatic growth hormone-releasing factor-40 (hpGRF-40) allows stimulation of GH release by TRH.
    Borges JL; Uskavitch DR; Kaiser DL; Cronin MJ; Evans WS; Thorner MO
    Endocrinology; 1983 Oct; 113(4):1519-21. PubMed ID: 6413195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the variations of female sex hormones during the menstrual cycle upon serum somatomedin and growth-promoting activity.
    Guidoux S; Garnier PE; Schimpff RM
    Horm Res; 1986; 23(1):31-7. PubMed ID: 3079724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and somatomedin-C response to synthetic human pancreatic tumor GH-releasing factor in hypopituitary and constitutionally short children.
    Minuto F; Barreca A; Del Monte P; Mauri R; Resentini M; Fortini P; Morabito M; Giordano G
    J Endocrinol Invest; 1986 Dec; 9(6):447-52. PubMed ID: 3106458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs.
    Heiman ML; Nekola MV; Murphy WA; Lance VA; Coy DH
    Endocrinology; 1985 Jan; 116(1):410-5. PubMed ID: 2856874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.